Showing results (161-170 of 213) with videos related to
Sort By:
Pageof 22
Frontiers in Pharmacology|June 3, 2016
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?Yvonne W S Jauw, C Willemien Menke-van der Houven van Oordt, Otto S Hoekstra, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of BiopharmaceuticalsGuus A M S van Dongen, Wissam Beaino, Albert D Windhorst, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2016
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PETDanielle J Vugts, Chris Klaver, Claudia Sewing, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Preclinical Evaluation of 89Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal FibrosisOlli Moisio, Jenni Virta, Emrah Yatkin, et al.Plos One|January 14, 2014
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)Pieter J Gaillard, Chantal C M Appeldoorn, Rick Dorland, et al.Bioconjugate Chemistry|August 23, 2011
Synthesis of phosphine and antibody-azide probes for in vivo Staudinger ligation in a pretargeted imaging and therapy approachDanielle J Vugts, Annelies Vervoort, Marijke Stigter-van Walsum, et al.Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2020
Targeted Brain Tumor Radiotherapy Using an Auger EmitterGiacomo Pirovano, Stephen A Jannetti, Lukas M Carter, et al.Molecular Imaging and Biology|August 2, 2024
Investigation of the Impact of the H310A FcRn Region Mutation on 89Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta AntibodyThomas E Wuensche, Natascha Stergiou, Iris Mes, et al.Molecular Pharmaceutics|May 31, 2022
Pretargeted PET of Osteodestructive Lesions in DogsCharles A Maitz, Samantha Delaney, Brendon E Cook, et al.Pageof 22